Medidata Solutions (MDSO) Receives a Hold from Wells Fargo

Wells Fargo analyst Jamie Stockton maintained a Hold rating on Medidata Solutions (MDSO) today. The company’s shares opened today at $91.45.

According to TipRanks.com, Stockton is a 3-star analyst with an average return of 2.4% and a 37.3% success rate. Stockton covers the Technology sector, focusing on stocks such as Computer Programs and Systems, Inc., Wageworks Inc, and Benefitfocus.

Medidata Solutions has an analyst consensus of Hold, with a price target consensus of $88.29, which is a -3.5% downside from current levels. In a report released yesterday, J.P. Morgan also upgraded the stock to Hold with a $92.25 price target.

See today’s analyst top recommended stocks >>

Based on Medidata Solutions’ latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $11.15 million. In comparison, last year the company had a net profit of $10.33 million.

Based on the recent corporate insider activity of 56 insiders, corporate insider sentiment is neutral on the stock. Last month, Carlos Dominguez, a Director at MDSO bought 11,820 shares for a total of $82,740.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Medidata Solutions, Inc. provides cloud based solutions for life sciences for customer’s clinical development processes including concept, conclusion, research optimization, and development investments. Its cloud-based technology including its unified platform, pioneering analytics, and clinical technology allows the development of new therapies pharmaceutical companies, biotech, and medical device firms, academic medical centers and contract research organizations around the world. It operates through the following geographical segments: United States, Japan, and Other. The company was founded by Glen M. de Vries, Edward F. Ikeguchi and Tarek A. Sherif in June 1999 and is headquartered in New York, NY.